drugset / Trial / NCT05340829
Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia
Non-randomizedSequentialOpen-labelTreatment
Summary
This is an open label, phase I study to assess the safety and efficacy of ThisCART19A in patients with AIDS related B cell lymphoma/lympholeukemia.
Timeline
- Start
- 2022-03-18
- Primary completion
- 2024-03-30
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ThisCART19A | Cell therapy | 2e+06 cells/kg | — |
| Subject | ThisCART19A | Cell therapy | 3e+06 cells/kg | — |
| Subject | ThisCART19A | Cell therapy | 4e+06 cells/kg | — |